|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 90 No. 11 (December 1), 1997:
pp. 4341-4353
The Bmx Tyrosine Kinase Induces Activation of the Stat Signaling Pathway, Which Is Specifically Inhibited by Protein Kinase C
By
Pipsa Saharinen,
Niklas Ekman,
Krista Sarvas,
Peter Parker,
Kari Alitalo, and
Olli Silvennoinen
From the Department of Virology, Haartman Institute, University of Helsinki, Finland; Molecular and Cancer Biology Laboratory, Haartman Institute, University of Helsinki, Finland; Imperial Cancer Research Fund, London, UK; and Institute of Medical Technology, University of Tampere, Finland.
 |
ABSTRACT |
Members of the hematopoietically expressed Tec tyrosine kinase family have an important role in hematopoietic signal transduction, as exemplified by the crucial role of Btk for B-cell differentiation and activation. Although a variety of cell surface receptors have been found to activate Tec tyrosine kinases, the specific signaling pathways and substrate molecules used by Tec kinases are still largely unknown. In this study a Tec family kinase, Bmx, was found to induce activation of the Stat signaling pathway. Bmx induced the tyrosine phosphorylation and DNA binding activity of all the Stat factors tested, including Stat1, Stat3, and Stat5, both in mammalian and insect cells. Bmx also induced transcriptional activation of Stat1- and Stat5-dependent reporter genes. Other cytoplasmic tyrosine kinases, Syk, Fyn, and c-Src, showed no or only weak ability to activate Stat proteins. Expression of Bmx in mammalian cells was found to induce activation of endogenous Stat proteins without activation of endogenous Jak kinases. We further analyzed the Bmx-mediated activation of Stat1, which was found to be regulated by protein kinase C  (PKC) isoform, but not  1,  , or  isoforms, leading to inhibition of Stat1 tyrosine phosphorylation. In conclusion, these studies show that Bmx, a Tec family kinase, can function as an activator of the Stat signaling pathway and identify a role for PKC in the regulation of Bmx signaling.
| |
INTRODUCTION |
PROTEIN TYROSINE phosphorylation is a central signaling mechanism for the growth and differentiation responses in hematopoietic cells. The majority of hematopoietic cell surface receptors, including cytokine and antigen receptors, lack the ability to phosphorylate protein substrates directly. Instead, ligand-induced receptor activation is coupled to downstream signaling events through receptor-associated cytoplasmic protein tyrosine kinases.1
A group of hematopoietically expressed cytoplasmic tyrosine kinases, termed the Tec tyrosine kinase family, has an important role in hematopoietic signal transduction and hematopoietic cell development.2 This family consists of the founder member Tec, Btk, Itk/Tsk/Emt, Txk, and Bmx tyrosine kinases, which share a characteristic domain structure including an amino-terminal pleckstrin homology (PH) domain, Tec homology (TH), src homology 3 (SH3) and 2 (SH2) domains, and a carboxy-terminal catalytic tyrosine kinase domain. Each Tec family kinase has its specific expression pattern. Expression of Btk is restricted to B-lymphoid and myeloid lineages, Itk is expressed predominantly in cells of T-lymphoid lineage, and Txk is expressed in myeloid and T cells, whereas the Tec tyrosine kinase is more widely expressed in hematopoietic cells.2 The expression of Bmx kinase is restricted to myeloid cells and certain endothelial cells.3,4
Thus far the biological functions for two Tec kinases, Btk and Itk, have been revealed and found to be regulating cell type-specific responses, consistent with the restricted expression pattern of these kinases. Naturally occurring mutations in the Btk gene result in human x-linked agammaglobulinemia (XLA) and murine x-linked immunodeficiency (Xid).5,6 The XLA phenotype is characterized by a lack of mature B cells due to developmental defects during pre-B-cell expansion.7,8 Recent studies have also shown that Itk plays a central role in T-cell signaling. Itk knockout mice have reduced numbers of mature thymocytes and show alterations in T-cell antigen receptor signaling.9
Several Tec family tyrosine kinases associate with and are activated through various hematopoietic cell surface receptors. Btk has been found to be activated through the mast cell FcR, B-cell antigen receptor, interleukin-5 receptor (IL-5R), and the IL-6 cytokine family signal transducer, gp130.10-14 Tec is activated through gp130, the receptor tyrosine kinase c-kit, and the IL-3R chain,14-16 whereas Itk is activated through ligation of CD28 in T cells and FcR in mast cells.17,18 Thus far no activating receptor has been identified for the Bmx kinase. Activation by multiple cell surface receptors suggests that Tec kinases could directly activate signaling pathways from these receptors. However, the specific target proteins and downstream signaling pathways for Tec kinases and their exact roles in cytokine signaling are still largely unknown. Thus far the only substrate for Tec family kinases is phospholipase  (PLC), which has been found to be regulated by Btk together with Syk following B-cell antigen receptor activation.19
Some of the molecular mechanisms regulating Btk activity have been characterized. Activation of Btk after B-cell receptor crosslinking is preceded by activation of Src family kinases and the Src kinases have been found to be critical regulators of Btk activity. The Src kinase Lyn binds directly through its SH3 domain to the proline-rich region of Btk and phosphorylates tyrosine 551 in the Btk catalytic domain.20-22 This results in enhanced Btk activity and subsequent Btk autophosphorylation at a second site, tyrosine 223 in the SH3 domain.22,23 Btk also associates through its PH domain with subunits of heterotrimeric G proteins and with various isoforms of protein kinase C (PKC).24,25 The interaction with PKC leads to downregulation of Btk activity.25 PKC may be a general regulator for Tec kinases, because Itk has also been found to interact with multiple PKC isoforms.18 However, this interaction results in activation of Itk catalytic activity.18
View larger version (52K):
[in this window]
[in a new window]
View larger version (46K):
[in this window]
[in a new window]
View larger version (22K):
[in this window]
[in a new window]
| Fig 1.
Coexpression of Bmx induces activation of Stat1. (A) COS cells were transfected with Stat1 expression vector together with Bmx, Jak1, Jak2, or control expression vectors, as indicated. Stat1 was immunoprecipitated from cell lysates using anti-HA antibody. The immunoprecipitates were electrophoresed in 7.5% SDS-PAGE, transferred to nitrocellulose membrane, and immunoblotted with anti-phosphotyrosine antibody. Shown in the lower panel is an immunoblot from total cell lysates electrophoresed in 7.5% SDS-PAGE blotted with anti-Stat1 antibody. (B) COS cells were transfected with Stat1 expression vector together with Bmx, Jak1, Jak2, or control expression vectors, as shown. Eight micrograms of protein from each lysate of transfected cells was incubated with 32P-labeled GAS oligonucleotide and analyzed in the mobility shift assay in 4.5% TBE-PAGE. The Bmx, Jak1, and Jak2 lysates were also supershifted using anti-HA antibody (for Stat1-HA). Shown in the lower panel is an immunoblot from total cell lysates electrophoresed in 7.5% SDS-PAGE blotted for Stat1 using anti-HA antibody. (C) COS cells were transfected with Stat1 expression vector alone or together with Bmx-HA, Syk, Fyn, or c-Src expression vectors. Lysates were analyzed in the mobility shift assay as above. Shown in the lower panels are immunoblots from total cell lysates electrophoresed in 7.5% SDS-PAGE blotted with anti-phosphotyrosine antibody and anti-Stat1 antibody. The autophosphorylated Syk, Fyn, and c-Src polypeptides are indicated by asterisks.
|
|
View larger version (82K):
[in this window]
[in a new window]
View larger version (51K):
[in this window]
[in a new window]
View larger version (20K):
[in this window]
[in a new window]
| Fig 2.
Coexpression of Bmx induces activation of Stat3. (A) COS cells were transfected with Stat3 expression vector together with Syk, Fyn, c-Src, Bmx-HA, or Jak2-HA expression vectors. Lysates were analyzed in the mobility shift assay using 33P-labeled SIE oligonucleotide. Lysates expressing Stat3 and Bmx-HA or Jak2-HA were supershifted using anti-Stat3 antibody. (B) The same lysates were electrophoresed in 7.5% SDS-PAGE and Western immunoblotted with anti-phosphotyrosine antibody or anti-Stat3 antibody. The autophosphorylated c-Src, Fyn, and Syk polypeptides are indicated by asterisks. (C) The Bmx-HA and Jak-HA containing lysates were also immunoblotted using anti-HA antibody.
|
|
View larger version (43K):
[in this window]
[in a new window]
View larger version (17K):
[in this window]
[in a new window]
| Fig 3.
Coexpression of Bmx induces activation of Stat5. (A) COS cells were transfected with Stat5 expression vector alone or together with Bmx-HA expression vector. Cell lysates were electrophoresed in 7.5% SDS-PAGE and Western immunoblotted with anti-Stat5 and anti-phosphotyrosine antibodies. (B) The same lysates were analyzed in a mobility shift assay using 32P-labeled oligonucleotide from the promoter of the -casein gene. The lysates were also supershifted with anti-Stat5 antibody.
|
|
Stat transcription factors (signal transducers and activators of transcription) are essential mediators of cytokine-induced gene expression, and their activation is mediated through induction of tyrosine phosphorylation.26 Cytokines activate receptor-associated Jak tyrosine kinases (Jak1, Jak2, Jak3, and Tyk2), which are required for phosphorylation of receptor-recruited Stat transcription factors (Stats 1, 2, 3, 4, 5A, 5B, and 6).26 Tyrosine-phosphorylated Stats dimerize through their SH2 domains to form homodimers or heterodimers, which are subsequently translocated to the nucleus. In addition to tyrosine phosphorylation, serine phosphorylation of at least Stat1 and Stat3 is required for their optimal activity as transcriptional activators.27 Stats are critical mediators of the cytokine-specific responses, including differentiation of hematopoietic cells. For example, Stat4 is required for IL-12-mediated differentiation of Th1 cells, and Stat6 is crucial for the development of IL-4-dependent Th2 responses.28-31
The present study was undertaken to explore the cellular signaling mechanisms used by a Tec family tyrosine kinase, Bmx. Like the other Tec kinases, Bmx contains the PH, SH2, and kinase domains, whereas the short proline-rich region implicated in interactions with Src kinases is missing, and the SH3 domain does not conform to the consensus characteristics.4 Bmx was originally cloned from bone marrow cells and has recently been shown to be expressed early in myeloid differentiation and in myeloid leukemias.3,4 Therefore, Bmx could be involved in hematopoietic receptor signaling, and here we have investigated the possible role of the Bmx kinase in activation of the Stat signaling pathway.
| |
MATERIALS AND METHODS |
Cell culture and transfections.
COS-7 and 293T cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS; GIBCO BRL, Life Technologies, Gaithersburg, MD) and antibiotics. Transfections were done using the Calcium-Phosphate Transfection kit (GIBCO) according to manufacturer's instructions. The cells were obtained 72 hours after transfection for immunoprecipitation and electrophoretic gel mobility shift assay and after 48 hours for luciferase assay. Sf9-insect cells were grown in Sf900 medium (GIBCO) with 10% FBS (GIBCO) and antibiotics.
DNA constructs.
Hemagglutinin (HA)-epitope was added to the 3' terminus of Bmx cDNA4 in Bluescript SK (Stratagene, La Jolla, CA). A polymerase chain reaction (PCR) fragment of Bmx, containing the DNA sequence for the HA-epitope, was amplified using 5'-TAT GTC AGT TCA GTC GGA-3' and 5'-CGT GTC GAC TCA AGC GTA ATC TGG AAC ATC GTA TGG GTA ATG CTT GTC TTT TTC CCG AAG-3' oligonucleotides. This fragment was used to replace the 3' BstXI-EcoRV fragment of Bmx in Bluescript SK. Full-length HA-tagged Bmx was cleaved out as a BssHII-Sal I fragment and cloned into Mlu I-Sal I sites of the pCI-Neo expression vector (Promega, Madison, WI), creating the Bmx-HA expression vector.
View larger version (22K):
[in this window]
[in a new window]
View larger version (21K):
[in this window]
[in a new window]
| Fig 4.
Bmx induces Stat-mediated transcription. (A) COS cells were transfected with Stat1 expression vector together with a luciferase reporter vector containing a wild-type (wt) or a mutant GAS-site (mut-GAS). In addition, cells were transfected with Jak2 or Bmx expression vectors. In control lysates cells were transfected with wild-type GAS luciferase construct alone or together with Stat1 expression vector. Cell lysates were analyzed for Stat1-dependent luciferase activity normalized to constitutively expressed luciferase activity from a cotransfected control vector (see Materials and Methods for details). The values shown are means from three independent experiments and standard errors of the mean. (B) COS cells were transfected with a luciferase reporter containing a Stat5 binding site from the promoter region of the Spi gene. Additionally the cells were transfected with Bmx-HA, Jak2-HA, or Jak1 expression vectors or with an empty vector as a control. Cell lysates were analyzed for Stat5-dependent luciferase activity as in (A).
|
|
View larger version (53K):
[in this window]
[in a new window]
| Fig 5.
Induction of endogenous GAS-binding activity by Bmx expression. COS cells were transfected with Bmx, Jak2, or control expression vectors, as shown, and nuclear extracts of transfected cells were prepared. Endogenous Stat activation was analyzed in the mobility shift assay using 32P-labeled IRF-1 GAS oligonucleotide. The same lysates were also incubated with anti-Stat1 antibody (ISGF3 [p91]) before mobility shift analysis with the IRF-1 GAS probe. As a control we analyzed a COS lysate containing overexpressed Stat1 and Bmx.
|
|
View larger version (25K):
[in this window]
[in a new window]
View larger version (43K):
[in this window]
[in a new window]
| Fig 6.
Bmx does not phosphorylate endogenous Jak kinases. (A) 293T cells were transfected with Bmx-HA expression vector or left without transfection. Jak1 was immunoprecipitated from cell lysates using anti-Jak1 antibody and the immunoprecipitates were electrophoresed in 6% SDS-PAGE followed by Western immunoblotting using anti-Jak1 or anti-phosphotyrosine antibodies. The Ig heavy chains are indicated by an asterisk. (B) Total cell lysates were electrophoresed in 6% SDS-PAGE followed by Western immunoblotting with anti-phosphotyrosine antibodies.
|
|
View larger version (22K):
[in this window]
[in a new window]
View larger version (46K):
[in this window]
[in a new window]
View larger version (42K):
[in this window]
[in a new window]
| Fig 7.
Induction of Stat3 tyrosine phosphorylation in insect cells. Sf9 cells were infected with Stat3 baculovirus alone or together with Bmx or Jak2 viruses or left uninfected. The cells were lysed 72 hours following infection and the lysates were immunoprecipitated using anti-Stat3 antibodies (A), anti-HA antibodies (Bmx) (B), or anti-Jak2 antibodies (C). The immunoprecipitates were electrophoresed in 7.5% SDS-PAGE, followed by Western immunoblotting using anti-phosphotyrosine antibodies, anti-Stat3 antibodies, anti-HA antibodies, or anti-Jak2 antibodies, as indicated. The anti-phosphotyrosine blot of Stat3-immunoprecipitate from Jak2 coinfected cells (A) is a longer exposure, as we repeatedly found weaker Stat3 tyrosine phosphorylation in Jak2 coinfections than in Bmx coinfections.
|
|
View larger version (40K):
[in this window]
[in a new window]
View larger version (53K):
[in this window]
[in a new window]
| Fig 8.
Induction of Stat1 tyrosine phosphorylation in insect cells. (A) Sf9 cells were infected with Stat1 baculovirus alone or together with Bmx or Jak2 viruses or left uninfected. The cells were lysed 72 hours following infection, and the lysates were immunoprecipitated using anti-ISGF-3(p91) antibodies. The immunoprecipitates were electrophoresed in 7.5% SDS-PAGE, followed by Western immunoblotting using anti-phosphotyrosine antibodies or anti-Stat1 antibodies as indicated. (B) Equal amounts of protein from the lysates used in (A) were electrophoresed in 7.5% SDS-PAGE and Western immunoblotted with anti-phosphotyrosine antibodies. The tyrosine phosphorylated Bmx and Jak2 kinases are indicated by asterisks.
|
|
View larger version (39K):
[in this window]
[in a new window]
View larger version (37K):
[in this window]
[in a new window]
| Fig 9.
Coexpression of PKC inhibits Bmx-induced DNA binding of Stat1. (A) Bmx (3 µg) and Stat1 (4 µg) expression vectors were transfected into COS cells together with expression vectors for the indicated PKC isoforms (4 µg), as shown. Cell lysates were analyzed in the mobility shift assay using 32P-labeled IRF-1 GAS oligonucleotide. First lane shows the 32P-labeled GAS oligonucleotide without cell lysate. Shown in the lower panel is an immunoblot from total cell lysates electrophoresed in 7.5% SDS-PAGE blotted for Stat1 using anti-HA antibodies. (B) The dose dependence of PKC inhibition of Stat1 DNA binding was evaluated by cotransfecting COS cells with expression vectors for Bmx (3 µg) and Stat1 (4 µg) and the indicated amounts of either PKC1 or PKC vectors. Cell lysates were analyzed in the mobility shift assay using 32P-labeled IRF-1 GAS oligonucleotide. Shown in the lower panel is an immunoblot from total cell lysates electrophoresed in 7.5% SDS-PAGE blotted for Stat1 using anti-HA antibodies.
|
|
View larger version (48K):
[in this window]
[in a new window]
| Fig 10.
Coexpression of PKC inhibits Bmx-induced tyrosine phosphorylation of Stat1. Stat1 (4 µg) and Bmx (3 µg) expression vectors were transfected into COS cells together with the PKC vectors (4 µg). Stat1 was immunoprecipitated from cell lysates using anti-HA antibodies. The immunoprecipitates were separated in 7.5% SDS-PAGE, transferred to nitrocellulose membrane, and probed for anti-phosphotyrosine. Shown in the lower panel is an immunoblot from total cell lysates electrophoresed in 7.5% SDS-PAGE probed for Stat1 using anti-HA antibodies.
|
|
Jak1 and Jak2 expression vectors have been previously described.32,33 HA-epitope was added to the 3' end of Jak2 cDNA cloned into the RK5 expression vector. A PCR fragment containing the sequence for HA-epitope was obtained with oligonucleotides 5'-AAG GCC AGA AGG ATG CCC AGA T-3' and 5'-TAG ATA TCG CGG CCG CCT AAG CGT AGT CAG GGA CGT CGT ACG GAT ACG CAG CTA TAC TGT CCC GGA-3' and cloned into Bcl I-EcoRV sites of Jak2 in RK5. The HA-epitope-tagged Jak2 was cloned as a Sal I-EcoRV fragment into Sal I-Sma I sites of pCI-Neo vector, creating the Jak2-HA expression vector.
Expression vectors for different PKC isoforms34-37 and for c-Src and Fyn kinases32 have been previously described. Luciferase reporter constructs with wild-type and mutated gamma interferon-activated sequence (GAS) oligonucleotides,38 the Spi luciferase vector,39 and expression vectors for Syk,40 HA-epitope-tagged Stat1,41 Stat3,42 and Stat5A43 were kind gifts from Drs Richard Pine, Gunnar Norstedt, Tomas Mustelin, Chris Schindler, James N. Ihle, and Berndt Groner, respectively, and have all been previously described.
Jak2-expressing baculovirus was constructed by cloning Jak2 cDNA into pVL1392 and transfecting it together with baculovirus DNA into Sf9 insect cells. Bmx-expressing baculovirus was constructed by cloning the HA-tagged Bmx cDNA into pBluebac4 (Invitrogen, San Diego, CA) and using the Bac-N-Blue Transfection Kit (Invitrogen) for creating the virus. The Stat1 and Stat3 baculoviruses were kind gifts from Dr James N. Ihle.
Antibodies.
Anti-phosphotyrosine antibody (clone 4G10) was from Upstate Biotechnology (Lake Placid, NY). Polyclonal anti-Jak2 antibody was described previously.32 Anti-HA-epitope antibody (clones 12CA5 and 16B12) was from Berkeley Antibody Company (Richmond, CA). Monoclonal anti-Stat1(p91), anti-ISGF-3(p91), anti-Stat3, and anti-Jak1 antibodies were from Transduction Laboratories (Lexington, KY). Polyclonal anti-Stat5 antibody was from Santa Cruz Biotechnology (Santa Cruz, CA).
Immunoprecipitation and Western blotting.
For immunoprecipitation, cells were lysed in Triton lysis buffer (50 mmol/L Tris-HCl, pH 7.5, 10% glycerol, 150 mmol/L NaCl, 1 mmol/L EDTA, 1% Triton X100, 50 mmol/L NaF, 1 mmol/L Na3VO4 ) supplemented with phenylmethylsulfonyl fluoride (PMSF ), aprotinin, leupeptin, and pepstatin A or in boiling sodium dodecyl sulfate (SDS) lysis buffer (0.5% SDS, 0.05 mmol/L Tris-HCl, pH 8, 1 mmol/L dithiothreitol (DTT), 50 mmol/L NaF, 1 mmol/L Na3VO4 ) for immunoprecipitation of Stat3. The SDS lysates were diluted with 1.5× RIPA buffer (1.25% NP-40, 1.25% sodium deoxycholate, 12.5 mmol/L NaH2PO4 , pH 7.2, 2 mmol/L EDTA, 50 mmol/L NaF, 1 mmol/L Na3VO4 with protease inhibitors) before immunoprecipitation. Immunoprecipitation was performed by incubating with specific antibodies for 2 to 3 hours followed by incubating with protein-A-Sepharose (Sigma, St Louis, MO) or with protein-G-Sepharose (Pharmacia, Uppsala, Sweden) for 1 to 1.5 hours. Immunoprecipitates were washed four times with Triton lysis buffer followed by elution with reducing Laemmli sample buffer. Immunoprecipitates, and samples of total cell lysates, were separated in SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to nitrocellulose membrane (Micron Separation Inc, Westborough, MA). Equal amounts of protein from cell lysates were always used for immunoprecipitations and Western blotting of total cell lysates. Protein concentrations of the lysates were measured using the BioRad Protein Assay system (Bio-Rad Laboratories, Hercules, CA). Immunodetection was performed using specific primary antibodies, biotinylated anti-mouse or anti-rabbit secondary antibodies (Dako A/S, Denmark), and streptavidin-biotin horseradish peroxidase-conjugate (Amersham Life Science, UK) followed by ECL (Amersham) or using specific primary antibodies and HRP-conjugated anti-mouse or anti-rabbit secondary antibodies (Amersham) and ECL detection (Amersham).
Electrophoretic gel-mobility shift assay.
For gel-mobility shift assay, cells were lysed in WCE lysis buffer (50 mmol/L Tris-HCl, pH 8, 0.5% NP-40, 10% glycerol, 0.1 mmol/L EDTA, 150 mmol/L NaCl, 50 mmol/L NaF, 0.5 mmol/L Na3VO4 ) supplemented with protease inhibitors. Eight micrograms of protein from total cell lysate was used in each mobility shift reaction. Annealed GAS oligonucleotide (GAS site of murine IRF-1 gene, 5'-CTA GAG CCT GAT TTC CCC GAA ATG ATG AG-3') or high-affinity SIS inducible element (SIE) oligonucleotide (5'-GAT CAG CAT TTC CCG TAA ATC CC-3') was end-labeled by T4 polynucleotide kinase using [-32P]adenosine triphosphate (ATP) or [-33P]ATP (Amersham). A total of 0.05 ng of 32P-labeled oligonucleotides or 0.5 ng of 33P-labeled oligonucleotides was used per reaction. Specifically, cell lysates and 200 ng poly-dI-dC (Pharmacia) were incubated on ice for 15 minutes followed by additional 15-minute incubation after adding labeled GAS/SIE oligonucleotide. Reactions were analyzed in 4.5% Tris Borate EDTA (TBE)-PAGE (2.2× TBE concentration) followed by autoradiography. For supershift analysis, WCE lysates were incubated with specific antibodies 30 minutes on ice before adding poly-dI-dC and labeled oligonucleotides. Stat5 gel-mobility shift assay was performed as described above except that annealed oligonucleotide corresponding to the Stat5 binding site in the -casein gene promoter (5'-AGATTTCTAGGAATTCAAATCC-3') was used in the binding reactions. Twenty-four femtomoles of probe labeled by end-filling with Klenow and [32P]dCTP (Amersham) was used in each reaction, and the reactions were analyzed in 4.5% TBE-PAGE (0.25× TBE concentration).
Nuclear extracts were prepared as described earlier.44 In brief, cells were lysed in buffer A (50 mmol/L HEPES, pH 7.5, 100 mmol/L NaF, 10 mmol/L sodium pyrophosphate, 2 mmol/L Na3VO4 , 2 mmol/L sodium molybdate, 2 mmol/L EDTA [PSB buffer], 0.2% NP-40, 10 mmol/L magnesium chloride, and protease inhibitors) and centrifuged. The nuclei were washed once with buffer B (same as A without NP-40), and finally lysed in buffer C (PSB with 0.1% NP-40, 0.3 mmol/L NaCl, 10% glycerol, and protease inhibitors). Nuclear extracts (6 µg), poly-dI-dC (240 ng/µL), bovine serum albumin (BSA; 1.5 mg/mL) and 32P-labeled GAS oligonucleotide (0.05 ng) were incubated 30 minutes at room temperature, and the reactions were resolved in 4.5% TBE (0.25×) PAGE, followed by autoradiography. For supershift analysis, nuclear extracts were incubated with anti-ISGF3 antibodies (0.25 µg) 40 minutes on ice before adding poly-dI-dC, BSA, and labeled GAS oligonucleotide.
Luciferase assay.
For luciferase assay, cells were transfected with Stat-dependent reporter constructs together with a pRLTK control vector constitutively expressing Renilla luciferase (Promega). Cells were lysed in Passive lysis buffer (Promega), and luciferase activity of the lysates was determined using Dual-Luciferase Reporter Assay System (Promega) according to manufacturer's instructions. The Stat-dependent luciferase activity was normalized to constitutively expressed Renilla luciferase activity.
| |
RESULTS |
Activation of Stat signaling pathway by the Bmx kinase.
The downstream signaling events for the Bmx tyrosine kinase were investigated by studying its possible role in activation of the Stat signaling pathway, which is used by multiple hematopoietic receptors. The activating receptor system for the Bmx kinase is currently not known, but the expression of Bmx in myeloid cells suggests its participation in hematopoietic receptor signaling.3
Overexpression of Bmx in COS cells resulted in its tyrosine phosphorylation, which was weakly visible as an approximately 76-kD tyrosine phosphorylated band in an anti-phosphotyrosine immunoblot of total cell lysates (Fig 1C). Immunoprecipitation of HA-epitope-tagged Bmx with anti-HA antibody followed by Western immunoblotting with anti-phosphotyrosine or in vitro immunocomplex kinase assay clearly showed that the immunoprecipitated Bmx was tyrosine phosphorylated and catalytically active (not shown).
To explore the ability of Bmx to activate Stat proteins, Bmx and Stat1 were coexpressed in COS cells. As positive controls we expressed Stat1 with Jak1 or Jak2, which have previously been shown to tyrosine phosphorylate different Stat proteins.1 Lysates from transfected cells were analyzed by immunoprecipitation of HA-epitope-tagged Stat1 using anti-HA-antibody, followed by anti-phosphotyrosine immunoblotting. Figure 1A shows that Stat1 became tyrosine phosphorylated in Bmx-transfected cells, as well as in Jak1- and Jak2-transfected cells. The control blot shows equal Stat1 expression in Bmx/Jak transfected lysates.
Induction of Stat1 DNA binding activity requires phosphorylation of a single C-terminal tyrosine residue.1 To investigate if Bmx-induced tyrosine phosphorylation was occurring at this activating tyrosine residue of Stat1, we analyzed the DNA binding activity of Bmx, Jak1, or Jak2 phosphorylated Stat1 in an electrophoretic mobility shift experiment (Fig 1B). The lysates were incubated with a 32P-labeled oligonucleotide representing the GAS site of the murine IRF-1 gene, which binds activated Stat dimers, including Stat1 homodimers. The Bmx kinase was found to induce retardation of the GAS oligonucleotide as efficiently as the Jak1 and Jak2 kinases (Fig 1B). When coexpressed with Stat3, Bmx was found to induce retardation of the labeled high-affinity SIE DNA sequence, a high-affinity binding site for Stat3 (Fig 2A). Bmx also induced tyrosine phosphorylation of Stat3 as shown in Fig 2B, and when coexpressed with Stat5, Bmx induced the tyrosine phosphorylation and DNA binding activity of Stat5 (Fig 3A and B). Figure 2C shows equal expression of HA-epitope-tagged Bmx and Jak2 kinases in the cell lysates analyzed in Fig 2A and B.
To evaluate the specificity of Bmx-induced Stat activation, we studied the ability of other cytoplasmic tyrosine kinases to induce Stat DNA binding activities in coexpression experiments with different Stat proteins in COS cells. Syk and the Src family kinases, Fyn and c-Src, showed much weaker activity in the mobility shift analysis of Stat1 (Fig 1C) and Stat3 (Fig 2A). In addition, overexpression of Syk, c-Src, and Fyn resulted in only weak induction of Stat3 tyrosine phosphorylation, whereas tyrosine phosphorylation of Stat3 was prominent in Bmx- and Jak2-expressing cells (Fig 2B). Anti-phosphotyrosine immunoblots of equal amounts of protein from total cell lysates revealed tyrosine phosphorylated bands corresponding to autophosphorylated Syk, Fyn, and c-Src kinases, confirming the expression and activation of these kinases in the cells (Figs 1C and 2B). The appearance of additional tyrosine phosphorylated bands in longer exposures also indicated tyrosine kinase activity of the transfected kinases toward endogenous substrates (not shown). This indicates that the ability to activate Stats is not merely correlated with overall kinase activity, and therefore, Stat proteins cannot be regarded as common substrates for cytoplasmic tyrosine kinases.
The DNA binding activity of Stat1 is not sufficient for optimal induction of Stat1-mediated transcriptional activation. The carboxy truncated splice variant Stat1, which lacks the C-terminal serine phosphorylation site, binds DNA following interferon gamma (IFN-) stimulation, but does not activate transcription.27 Therefore, we wanted to explore if activation of Bmx was sufficient to stimulate Stat1-dependent transcription. Stat1 and Bmx or Stat1 and Jak2 expression vectors were transfected into COS cells together with luciferase constructs containing either wild-type or mutant IRF-1 GAS site upstream of a thymidine kinase minimal promoter. An internal standard was used to normalize luciferase activity to the transfection efficiency. Bmx was found to activate transcription through the wild-type GAS site as efficiently as Jak2, but not through the mutant GAS site (Fig 4A). We also studied whether Bmx was able to induce Stat5-dependent transcription using a reporter construct of the promoter region of the Serine protease inhibitor (Spi) gene, which binds activated Stat5 dimers.39 COS cells were transfected with this reporter construct together with Stat5 and Bmx, Jak1 or Jak2 expression vectors. The results in Fig 4B show that Bmx induced Stat5 transactivation similarly to Jak1 or Jak2.
Activation of endogenous Jak/Stat proteins by Bmx expression.
We also explored whether Bmx was able to activate endogenous Stat proteins. Expression of Bmx alone in COS cells was found to induce GAS binding activity of endogenous Stat proteins to a similar extent as expression of Jak2 (Fig 5). By supershift experiments the GAS binding complex induced by both Jak2 and Bmx was found to be composed of Stat1 proteins. We also tested whether similar expression of Bmx induced activation of endogenous Jak kinases. 293 T cells transfected with Bmx were lysed and immunoprecipitated using anti-Jak1 antibody, followed by Western immunoblotting using anti-Jak1 or anti-phosphotyrosine antibodies (Fig 6). We could not detect Jak1 tyrosine phosphorylation either when Jak1 was immunoprecipitated from nontransfected control cells or cells transfected with Bmx expression vector. This suggests that expression of Bmx does not activate endogenous Jak1, and that Bmx-induced Stat activation is mediated independently of Jak kinases.
Activation of Stat proteins by Bmx in insect cells.
To explore the ability of Bmx to induce activation of Stat proteins also in insect cells, we infected Sf9 cells with Stat3 baculovirus either alone or together with Bmx or Jak2 viruses. The baculovirus-expressed Bmx and Jak2 kinases were found to be tyrosine phosphorylated in insect cells (Fig 7B and C). Tyrosine phosphorylation of Stat3 in coinfected cells was analyzed by immunoprecipitation of Stat3, followed by anti-phosphotyrosine immunoblotting. The results indicated that Bmx was able to induce Stat3 activation efficiently also in insect cells (Fig 7A). Similarly, we analyzed tyrosine phosphorylation of Stat1 induced by Bmx or Jak2 coinfection in insect cells (Fig 8). Figure 8A shows that both kinases induced tyrosine phosphorylation of Stat1.
Inhibition of Bmx-induced Stat1 activation by PKC. Activation of PKC by phorbol esters has been found to inhibit certain cytokine-mediated responses.45,46 In addition, several PKC isoforms have been found to interact with the Btk and Itk kinases modifying their kinase activity.18,25 These reports indicate that PKC may regulate cytokine-induced signaling and particularly may modulate signaling mediated by Tec family kinases. Therefore, we wanted to investigate possible regulation of the Bmx kinase by different PKC isoforms. COS cells were transfected with expression vectors for Stat1 and Bmx together with expression vectors for either 1, , , and PKC isoforms. The lysates were analyzed in a mobility shift assay using labeled IRF-1 GAS sequence as a probe. The Bmx-induced DNA binding activity of Stat1 was found to be inhibited by PKC, whereas the 1, , and PKC isoforms had no effect (Fig 9A). Expression of the different PKC isoforms was confirmed by Western immunoblotting of total cell lysates using specific anti-PKC antibodies (not shown). To examine the specificity of the inhibitory effect of PKC, we analyzed the dose-dependent effect of PKC and PKC1 on Bmx-induced Stat1 DNA binding activity (Fig 9B). PKC inhibited the Bmx-induced Stat1 DNA binding already at the lowest concentration tested, whereas PKC1 had no effect even when it was transfected over two times more than Bmx.
PKC inhibits tyrosine phosphorylation of Stat1.
Because tyrosine phosphorylation is required for the induction of DNA binding activity of Stat proteins, inhibition of Stat tyrosine phosphorylation was a potential mechanism for the inhibitory effect of PKC. However, tyrosine phosphorylation is not always sufficient for induction of Stat DNA binding activity. For example, in certain human cancer cell lines, IFN--induced gene expression has been found to be inhibited by proteins preventing the DNA binding of activated ISGF-3 complexes.47,48 To analyze these possibilities, COS cells were transfected with Stat1 and Bmx expression vectors together with PKC1 or PKC vectors. The cell lysates were analyzed by immunoprecipitation of Stat1 and Western immunoblotting with anti-phosphotyrosine. PKC, but not PKC1, was found to inhibit Bmx-induced tyrosine phosphorylation of Stat1 (Fig 10), indicating that the lack of Stat1 DNA binding activity in PKC coexpressions was caused by inhibition of Stat1 tyrosine phosphorylation.
| |
DISCUSSION |
In this study we have investigated the signaling mechanisms used by Bmx, a member of the Tec tyrosine kinase family. We analyzed the role of Bmx in activation of Stat transcription factors by studying the Bmx-induced Stat tyrosine phosphorylation and DNA binding to GAS or SIE DNA elements, which specifically bind different Stat factors. Expression of Bmx in COS cells induced endogenous GAS-binding activity, and when coexpressed, Bmx induced the DNA binding activity and tyrosine phosphorylation of Stat1, Stat3, and Stat5. Furthermore, we found that overexpression of Bmx was sufficient to induce transcriptional activation of Stat1- and Stat5-dependent reporter genes to the same extent as overexpression of Jak1 or Jak2. The specificity of Bmx-induced Stat activation was analyzed by comparing it with Stat activation induced by other cytoplasmic tyrosine kinases. Overexpressed Syk, c-Src, or Fyn showed much weaker ability to activate Stats as compared with Bmx or Jak2, illustrating clear differences in their substrate specificity. Also, Tec has been found neither to phosphorylate purified Stat1 in an in vitro immunocomplex kinase assay nor to induce tyrosine phosphorylation or DNA binding activity of Stat1 in insect cells.49 The various Tec family members appear to display clear differences in their substrate recognition, because we found that Bmx activated Stat1, Stat3, and Stat5 as efficiently as Jaks both in insect and mammalian cells. Based on these results, Stat activation is a likely downstream signaling event for the Bmx kinase also in vivo. The receptor system where Bmx is activated is not known yet, but it is interesting to note that Bmx was cloned from a bone marrow cDNA library, and we have detected Bmx RNA in CD34+ cells from cord blood as well as in granulocytes and myeloid leukemias.3
One possible explanation for Bmx-induced Stat activation is that Bmx induces activation of endogenous Jak kinases. However, two findings suggest that Bmx directly phosphorylates Stat proteins to activate them. First, we have not detected endogenous Jak activation in Bmx transfected cells (Fig 6), although Bmx is able to induce activation of DNA binding of endogenous Stat proteins (Fig 5). Furthermore, the transfected Bmx and Jak kinases were equally effective in induction of Stat activation. This would be unlikely if Bmx works through activation of an endogenous Jak kinase.
Previous studies indicate that besides the Jak kinases, other protein kinases can also directly activate Stat proteins. For example, receptors for epidermal growth factor (EGF ) and platelet-derived growth factor have been found to directly phosphorylate Stat proteins.49-52 In addition, engagement of the T-cell antigen receptor in purified peripheral blood T lymphocytes leads to activation of Stat1 and Stat3 without any detectable Jak activation.53 It is interesting to note that Stat activation has recently been found to occur within minutes after activation of the B-cell antigen receptor, although the Jak kinases have not been found to be associated with the antigen receptor.54 Therefore, it is reasonable to assume that in addition to Jaks, other tyrosine kinases may regulate the Stat pathway.
Enhanced activation of Stat proteins has been observed in cells transformed by v-Src, suggesting that v-Src directly activates Stat factors.55,56 Previous studies showed that overexpression of v-Src in NIH 3T3 cells activated Stat3, whereas overexpression of c-Src resulted in much weaker Stat3 activation.55 Stat1 was not activated in these experiments, which is in accordance with our results (Fig 1C). In longer exposures of our mobility shift and Western blot gels, we could also detect Stat1 and Stat3 activation by c-Src, but this activation was much weaker than that seen by Bmx or Jak kinases. One explanation is that activation of Src kinases is weaker in COS cells compared with strong activation of v-Src observed in fibroblastic cell lines. In our experiments the activity of c-Src as indicated by the magnitude of cellular tyrosine phosphorylation induced by c-Src expression was comparable with that induced by Bmx or Jak kinases. It should be noted that under physiological situations, such as stimulations with growth factors or cytokines, the level of Src activation and cellular phosphorylation is rather low.
Chaturvedi et al have recently shown that overexpression of v-Src in a myeloblastic cell line induces constitutive activation of Stat1, Stat3, and Stat5, and they suggest that only Stat3 is activated directly by v-Src.57 Furthermore, in the myeloid system v-Src is unable to induce constitutive Jak activation, although v-Src induces activation of Jak1 and Jak2 in NIH 3T3 fibroblasts.58 These results indicate that overexpression of the v-Src kinase has different effects on the Jak/Stat-signaling pathway in different cell types. Also, endogenous cytokine receptors use different Jaks and Stats in a cell type-specific manner.
Constitutive Stat activation has been also detected in myeloid and lymphoid leukemia cells.59,60 In Ph1 positive leukemia cell line, K562 constitutive activation of Stat5 has been shown to occur independently of Jak kinases, most probably through Bcr/Abl.61,62 Bmx is expressed in acute and chronic myeloid leukemia cells, and it will be of interest to study the possible role of Bmx in Stat activation in these cells.3
Activation of PKC commonly occurs in signal transduction through hematopoietic transmembrane receptors, and several isoforms of PKC have been found to regulate Tec family kinases.18,25 We found that PKC, but not 1, , or isoforms, inhibited the Bmx-mediated Stat1 activation by preventing tyrosine phosphorylation of Stat1. PKC has recently been found to be involved in many protein tyrosine phosphorylation-mediated signaling events. In these situations PKC often becomes tyrosine phosphorylated, which modulates its kinase activity. For example, substance P-, carbacol-, EGF-, and IgE-induced signaling pathways have been found to induce tyrosine phosphorylation of PKC, and activation of the Fc-receptor by IgE alters the substrate specificity of PKC.63-65 These reports thus provide evidence for interactions between tyrosine kinase signaling and enzymes of the PKC family, particularly PKC. We also found that coexpression of Bmx with PKC induced tyrosine phosphorylation of PKC, indicating possible regulation of PKC by Bmx (unpublished data of authors and Dr Imre Västrik, 1996).
The mechanism by which PKC inhibits Bmx-induced Stat activation is currently unknown, but several possibilities exist. First, PKC may downregulate the activity of Bmx by directly interacting with Bmx or through another PKC-activated kinase. Alternatively, PKC may activate a phosphatase capable of dephosphorylating Stats or Bmx. We are further analyzing these possibilities. However, we have not detected any differences in Bmx tyrosine phosphorylation or kinase activity on cotransfection of Bmx and PKC (unpublished data of the authors and Dr Imre Västrik, 1996). PKC-mediated, protein tyrosine phosphatase activation has previously been found to regulate Stat signaling pathways. For example, IFN- signaling in primary monocytes has been found to be inhibited by phorbol esters through an as yet uncharacterized protein tyrosine phosphatase.46 Phorbol esters have also been found to increase the catalytic activity and expression of the SH2-containing phosphatase, SHP-1, which is implicated in the downregulation of cytokine receptor signaling by dephosphorylating the Jak kinases.66-70
In conclusion, activation of the Bmx tyrosine kinase was found to lead to activation of Stat transcription factors. The Jak kinases are essential for Stat activation through cytokine receptors, but in noncytokine receptors Stat activation does not require Jak activation. In these instances other tyrosine kinases must be responsible for Stat activation.
| |
FOOTNOTES |
Submitted February 4, 1997;
accepted July 23, 1997.
Supported by the Academy of Finland, Finnish Cancer Society, and Sigrid Juselius Foundation.
Address reprint requests to Olli Silvennoinen, Department of Virology, Haartman Institute, Haartmaninkatu 3, PO Box 21, FIN-00014 University of Helsinki, Helsinki, Finland.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be hearly marked
``advertisment'' in accordance with 18 U.S.C. section 1734 solely to
indicate this fact.
| |
ACKNOWLEDGMENT |
We thank Dr Eija Korpelainen for helpful discussions, Drs Imre Västrik and Elena Arighi for help and collaboration, and Drs Berndt Groner, James N. Ihle, Tomas Mustelin, Gunnar Norstedt, Richard Pine, and Chris Schindler for kindly providing the reagents specified in Materials and Methods.
| |
REFERENCES |
1.
Ihle JN,
Witthuhn BA,
Quelle FW,
Yamamoto K,
Silvennoinen O:
Signalling through the hematopoietic cytokine receptors.
Annu Rev Immunol
13:369,
1995[Medline]
[Order article via Infotrieve]
2.
Rawlings DJ,
Witte ON:
The Btk subfamily of cytoplasmic tyrosine kinases: Structure, regulation and function.
Semin Immunol
7:237,
1995[Medline]
[Order article via Infotrieve]
3.
Kaukonen J,
Lahtinen I,
Laine S,
Alitalo K,
Palotie A:
Bmx tyrosine kinase is expressed in granulocytes and myeloid leukaemias.
Br J Haematol
94:455,
1996[Medline]
[Order article via Infotrieve]
4.
Tamagnone L,
Lahtinen I,
Mustonen T,
Virtaneva K,
Francis F,
Muscatelli F,
Alitalo R,
Smith CIE,
Larsson C,
Alitalo K:
Bmx, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2.
Oncogene
9:3683,
1994[Medline]
[Order article via Infotrieve]
5.
Tsukada S,
Saffran DC,
Rawlings DJ,
Parolini O,
Allen RC,
Klisak I,
Sparkes RS,
Kubagawa H,
Mohandas T,
Quan S,
Belmont JW,
Cooper MD,
Conley ME,
Witte ON:
Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.
Cell
72:279,
1993[Medline]
[Order article via Infotrieve]
6.
Vihinen M,
Cooper MD,
de Saint Basile G,
Fischer A,
Good RA,
Hendriks RW,
Kinnon C,
Kwan SP,
Litman GW,
Notarangelo LD,
Ochs HD,
Rosen FS,
Vetrie D,
Webster ADB,
Zegers BJM,
Smith CIE:
International study group: BTKbase: A database of XLA-causing mutations.
Immunol Today
16:460,
1995[Medline]
[Order article via Infotrieve]
7.
Kerner JD,
Appleby MW,
Mohr RN,
Chien S,
Rawlings DJ,
Maliszewski CR,
Witte ON,
Perlmutter RM:
Impaired expansion of mouse B cell progenitors lacking Btk.
Immunity
3:301,
1995[Medline]
[Order article via Infotrieve]
8.
Khan WN,
Alt FW,
Gerstein RM,
Malynn BA,
Larsson I,
Rathbun G,
Davidson L,
Muller S,
Kantor AB,
Herzenberg LA,
Rosen FS,
Sideras P:
Defective B cell development and function in Btk deficient mice.
Immunity
3:283,
1995[Medline]
[Order article via Infotrieve]
9.
Liao XC,
Littman DR:
Altered T cell receptor signalling and disrupted T cell development in mice lacking Itk.
Immunity
3:757,
1995[Medline]
[Order article via Infotrieve]
10.
Kawakami Y,
Yao L,
Miura T,
Tsukada S,
Witte ON,
Kawakami T:
Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon FcRI crosslinking.
Mol Cell Biol
14:5108,
1994[Abstract/Free Full Text]
11.
Aoki Y,
Isselbacher KJ,
Pillai S:
Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells.
Proc Natl Acad Sci USA
91:10606,
1994[Abstract/Free Full Text]
12.
De Weers M,
Brouns GS,
Hinshelwood S,
Kinnon C,
Scuurman RKB,
Hendriks RW,
Borst J:
B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia.
Proc Natl Acad Sci USA
269:23857,
1994
13.
Sato S,
Katagiri T,
Takaki S,
Kikuchi Y,
Hitoshi Y,
Yonehara S,
Tsukada S,
Kitamura D,
Watanabe T,
Witte O:
IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases.
J Exp Med
180:101,
1994
14.
Matsuda T,
Takahashi-Tezuka M,
Fukada T,
Okuyama Y,
Fujitani Y,
Tsukada S,
Mano H,
Hirai H,
Witte ON,
Hirano T:
Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines.
Blood
85:627,
1995[Abstract/Free Full Text]
15.
Tang B,
Mano H,
Yi T,
Ihle JN:
Tec kinase associates with c-kit and is tyrosine phosphorylated and activated following stem cell factor binding.
Mol Cell Biol
14:8432,
1994[Abstract/Free Full Text]
16.
Mano H,
Yamashita Y,
Sato K,
Yazaki Y,
Hirai H:
Tec protein-tyrosine kinase is involved in interleukin-3 signalling pathway.
Blood
85:343,
1995[Abstract/Free Full Text]
17.
August A,
Gibson S,
Kawakami Y,
Kawakami T,
Mills GB,
Dupont B:
CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line.
Proc Natl Acad Sci USA
91:9347,
1994[Abstract/Free Full Text]
18.
Kawakami Y,
Yao L,
Tashiro M,
Gibson S,
Mills BG,
Kawakami T:
Activation and interaction with protein kinase C of a cytoplasmic tyrosine kinase, Itk/Tsk/Emt, on FcRI cross-linking on mast cells.
J Immunol
155:3556,
1996[Abstract]
19.
Takata M,
Kurosaki T:
A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-2.
J Exp Med
184:31,
1996[Abstract/Free Full Text]
20.
Cheng G,
Ye ZS,
Baltimore D:
Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction.
Proc Natl Acad Sci USA
91:8152,
1994[Abstract/Free Full Text]
21.
Mahajan S,
Fargnoli J,
Burkhardt AL,
Kut SA,
Saouaf SJ,
Bolen JB:
Src family protein tyrosine kinase induce autoactivation of Bruton's tyrosine kinase.
Mol Cell Biol
15:5304,
1995[Abstract]
22.
Rawlings DJ,
Scharenberg AM,
Park H,
Wahl MI,
Lin S,
Kato RM,
Fluckiger AC,
Witte ON,
Kinet JP:
Activation of Btk by a phosphorylation mechanism initiated by SRC family kinases.
Science
271:822,
1996[Abstract]
23.
Park H,
Wahl MI,
Afar DEH,
Turck CW,
Rawlings DJ,
Tam C,
Scharenberg AM,
Kinet JP,
Witte ON:
Regulation of Btk function by a major autophosphorylation site within the SH3 domain.
Immunity
4:515,
1996[Medline]
[Order article via Infotrieve]
24.
Tsukada S,
Rawlings DJ,
Witte ON:
Role of Bruton's tyrosine kinase in immunodeficiency.
Curr Opin Immunol
6:623,
1994[Medline]
[Order article via Infotrieve]
25.
Yao L,
Kawakami Y,
Kawakami T:
The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C.
Proc Natl Acad Sci USA
91:9175,
1994[Abstract/Free Full Text]
26.
Schindler C,
Darnell JE Jr:
Transcriptional responses to polypeptide ligands: The Jak/Stat pathway.
Annu Rev Biochem
64:621,
1995[Medline]
[Order article via Infotrieve]
27.
Wen Z,
Zhong Z,
Darnell JE Jr:
Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phophorylation.
Cell
82:241,
1995[Medline]
[Order article via Infotrieve]
28.
Kaplan MH,
Sun YL,
Hoey T,
Grusby MJ:
Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice.
Nature
382:174,
1996[Medline]
[Order article via Infotrieve]
29.
Thierfelder WE,
van Deursen JM,
Yamamoto K,
Tripp RA,
Sarawar SR,
Carson RT,
Sangster MY,
Vignali DAA,
Doherty PC,
Grosweld GC,
Ihle JN:
Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells.
Nature
382:171,
1996[Medline]
[Order article via Infotrieve]
30.
Shimoda K,
van Deursen J,
Sangster MY,
Sarawar SR,
Carson RT,
Tripp RA,
Chu C,
Quelle FW,
Nosaka T,
Vignali DAA,
Doherty PC,
Grosweld G,
Paul WE,
Ihle JN:
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.
Nature
380:630,
1996[Medline]
[Order article via Infotrieve]
31.
Takeda K,
Tanaka T,
Shi W,
Matsumoto M,
Minami M,
Kashiwamura S,
Nakanishi K,
Yoshida N,
Kishimoto T,
Akira S:
Essential role of Stat6 in IL-4 signalling.
Nature
380:627,
1996[Medline]
[Order article via Infotrieve]
32.
Silvennoinen O,
Ihle JN,
Schlessinger J,
Levy DE:
Interferon-induced nuclear signalling by Jak protein tyrosine kinases.
Nature
366:583,
1993[Medline]
[Order article via Infotrieve]
33.
Silvennoinen O,
Witthuhn BA,
Quelle FW,
Cleveland JL,
Yi T,
Ihle JN:
Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction.
Proc Natl Acad Sci USA
90:8429,
1993[Abstract/Free Full Text]
34.
Coussens L,
Parker PJ,
Rhee L,
Yang-Feng TL,
Chen E,
Waterfield MD,
Francke U,
Ullrich A:
Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signalling pathways.
Science
233:859,
1986[Abstract/Free Full Text]
35.
Olivier AR,
Parker PJ:
Expression and characterisation of PKC-.
Eur J Biochem
200:805,
1991[Medline]
[Order article via Infotrieve]
36.
Schaap D,
Parker PJ:
Expression, purification and characterization of protein kinase C-.
J Biol Chem
265:7301,
1990[Abstract/Free Full Text]
37.
Ways DK,
Posekany K,
deVente J,
Garris T,
Chen J,
Hooker J,
Qin W,
Cook P,
Fletcher D,
Parker P:
Overexpression of protein kinase C-zeta stimulates leukemic cell differentiation.
Cell Growth Differ
5:1195,
1994[Abstract]
38.
Pine R,
Canova A,
Schindler C:
Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN and IFN, and is likely to autoregulate the p91 gene.
EMBO J
13:158,
1994[Medline]
[Order article via Infotrieve]
39.
Sliva D,
Wood TJ,
Schindler C,
Lobie PE,
Norstedt G:
Growth hormone specifically regulates serine protease inhibitor gene transcription via gamma-activated sequence-like DNA element.
J Biol Chem
269:26208,
1994[Abstract/Free Full Text]
40.
Couture C,
Baier G,
Oetken C,
Williams S,
Telford D,
Marie-Cardine A,
Baier-Bitterlich G,
Fischer S,
Burn P,
Altman A:
Activation of p56lck by p72syk through physical association and N-terminal tyrosine phosphorylation.
Mol Cell Biol
14:5249,
1994[Abstract/Free Full Text]
41.
Schindler C,
Fu XY,
Improta T,
Aebersold R,
Darnell JE Jr:
Proteins of transcription factor ISGF-3: One gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon alpha.
Proc Natl Acad Sci USA
89:7836,
1992[Abstract/Free Full Text]
42.
Zhong Z,
Wen Z,
Darnell JE Jr:
Stat3 and Stat4: Members of the family of signal transducers and activators of transcription.
Proc Natl Acad Sci USA
91:4806,
1994[Abstract/Free Full Text]
43.
Wakao H,
Gouilleux F,
Groner B:
Mammary gland factor (MGF ) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response.
EMBO J
13:2182,
1994[Medline]
[Order article via Infotrieve]
44.
Mui ALF,
Wakao H,
O'Farrel AM,
Harada N,
Miyajima A:
Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two Stat5 homologs.
EMBO J
14:1166,
1995[Medline]
[Order article via Infotrieve]
45.
Chaikin E,
Ziltener HJ,
Razin E:
Protein kinase C plays an inhibitory role in interleukin 3- and interleukin 4-mediated mast cell proliferation.
J Biol Chem
265:22109,
1990[Abstract/Free Full Text]
46.
Petricoin E III,
David M,
Igarashi K,
Benjamin C,
Ling L,
Goelz S,
Finbloom DS,
Larner AC:
Inhibition of alpha interferon but not gamma interferon signal transduction by phorbol esters is mediated by a tyrosine phosphatase.
Mol Cell Biol
16:1419,
1996[Abstract]
47.
Kanda K,
Decker T,
Aman P,
Wahlstrom M,
von Gabain A,
Kallin B:
The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells affects induction of IFN-induced genes but not the activation of transcription factor ISGF-3.
Mol Cell Biol
12:4930,
1992[Abstract/Free Full Text]
48.
Petricoin E III,
David M,
Fang H,
Grimley P,
Larner AC,
Vande Pol S:
Human cancer cell lines express a negative transcriptional regulator of the interferon regulatory factor family of DNA binding proteins.
Mol Cell Biol
14:1477,
1994[Abstract/Free Full Text]
49.
Quelle FW,
Thierfelder W,
Witthuhn BA,
Tang B,
Cohen S,
Ihle JN:
Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor.
J Biol Chem
270:20775,
1995[Abstract/Free Full Text]
50.
David M,
Wong L,
Flavell R,
Thompson SA,
Wells A,
Larner AC,
Johnson GR:
STAT activation by epidermal growth factor (EGF ) and amphiregulin.
J Biol Chem
271:9185,
1996[Abstract/Free Full Text]
51.
Leaman DW,
Pisharody S,
Flickinger TW,
Commane MA,
Schlessinger J,
Kerr IM,
Levy DE,
Stark GR:
Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor.
Mol Cell Biol
16:369,
1996[Abstract]
52.
Vignais ML,
Sadowski HB,
Watling D,
Rogers NC,
Gilman M:
Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins.
Mol Cell Biol
16:1759,
1996[Abstract]
53.
Henttinen T,
Levy DE,
Silvennoinen O,
Hurme M:
Activation of the signal transducer and transcription (STAT) signalling pathway in a primary T cell response.
J Immunol
155:4582,
1995[Abstract]
54.
Karras JG,
Wang Z,
Coniglio SJ,
Frank DA,
Rothstein TL:
Antigen-receptor engagement in B cells induces nuclear expression of Stat5 and Stat6 proteins that bind and transactivate an IFN- activation site.
J Immunol
157:39,
1996[Abstract]
55.
Yu CL,
Meyer DJ,
Campbell GS,
Larner AC,
Carter-Su C,
Schwartz J,
Jove R:
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.
Science
269:81,
1995[Abstract/Free Full Text]
56.
Cao X,
Tay A,
Guy GR,
Tan YH:
Activation and association of Stat3 with Src in v-Src transformed cell lines.
Mol Cell Biol
16:1595,
1996[Abstract]
57.
Chaturvedi P,
Sharma S,
Reddy EP:
Abrogation of interleukin-3 dependence of myeloid cells by the v-Src oncogene requires SH2 and SH3 domains which specify activation of STATs.
Mol Cell Biol
17:3295,
1997[Abstract]
58.
Cambell GS,
Yu C-L,
Jove R,
Carter-Su C:
Constitutive activation of Jak1 in Src-transformed cells.
J Biol Chem
272:2591,
1997[Abstract/Free Full Text]
59.
Goulleux-Gruart V,
Goilleux F,
Desaint C,
Claisse JF,
Capiod JC,
Delobel J,
Weber-Nordt R,
Dusanter-Fourt I,
Dreyfus F,
Groner B,
Prin L:
STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients.
Blood
87:1692,
1996[Abstract/Free Full Text]
60.
Weber-Nordt RM,
Egen C,
Wehinger J,
Ludwig W,
Goilleux-Gruart V,
Mertelsman R,
Finke J:
Constituve activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.
Blood
88:809,
1996[Abstract/Free Full Text]
61.
Carlesso N,
Frank DA,
Griffin JD:
Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
J Exp Med
183:811,
1996[Abstract/Free Full Text]
62.
Ilaria RL,
Van Etten RA:
P210 and P190BCR/ABL induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members.
J Biol Chem
271:31704,
1996[Abstract/Free Full Text]
63.
Soltoff SP,
Toker A:
Carbacol, substance P, and phorbol ester promote the tyrosine phosphorylation of protein kinase C in salivary gland epithelial cells.
J Biol Chem
270:13490,
1995[Abstract/Free Full Text]
64.
Denning MF,
Dlugosz AA,
Threadgill DW,
Magnuson T,
Yuspa SH:
Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C.
J Biol Chem
271:5325,
1996[Abstract/Free Full Text]
65.
Haleem-Smith H,
Chang EY,
Szallasi Z,
Blmberg PM,
Rivera J:
Tyrosine phosphorylation of protein kinase C- in response to the activation of the high-affinity receptor for immunoglobulin E modifies its substrate recognition.
Proc Natl Acad Sci USA
92:9112,
1995[Abstract/Free Full Text]
66.
Rivard N,
McKenzie FR,
Brondello JM,
Pouyssegur J:
The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G-protein-coupled receptors.
J Biol Chem
270:11017,
1995[Abstract/Free Full Text]
67.
Uchida T,
Matozaki T,
Matsuda K,
Suzuki T,
Matozaki S,
Nakano O,
Wada K,
Konda Y,
Sakamoto C,
Kasuga M:
Phorbol ester stimulates the activity of a protein tyrosine phosphatase containing SH2 domains (PTP1C) in HL-60 leukemia cells by increasing gene expression.
J Biol Chem
268:11845,
1993[Abstract/Free Full Text]
68.
Yi T,
Mui ALF,
Krystal G,
Ihle JN:
Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis.
Mol Cell Biol
13:7577,
1993[Abstract/Free Full Text]
69.
Yi T,
Zhang J,
Miura O,
Ihle JN:
Hematopoietic cell phosphatase associates with erythropoietin (EPO) receptor after EPO-induced receptor tyrosine phosphorylation: Identification of potential binding sites.
Blood
85:87,
1995[Abstract/Free Full Text]
70.
Klingmüller U,
Lorenz U,
Cantley LC,
Neel BG,
Lodish HF:
Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals.
Cell
80:729,
1995[Medline]
[Order article via Infotrieve]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. A. Mitchell-Jordan, T. Holopainen, S. Ren, S. Wang, S. Warburton, M. J. Zhang, K. Alitalo, Y. Wang, and T. M. Vondriska
Loss of Bmx Nonreceptor Tyrosine Kinase Prevents Pressure Overload-Induced Cardiac Hypertrophy
Circ. Res.,
December 5, 2008;
103(12):
1359 - 1362.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kaur, A. Sassano, A. M. Joseph, B. Majchrzak-Kita, E. A. Eklund, A. Verma, S. M. Brachmann, E. N. Fish, and L. C. Platanias
Dual Regulatory Roles of Phosphatidylinositol 3-Kinase in IFN Signaling
J. Immunol.,
November 15, 2008;
181(10):
7316 - 7323.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Tu, D. Thotala, L. Geng, D. E. Hallahan, and C. D. Willey
Bone Marrow X Kinase-Mediated Signal Transduction in Irradiated Vascular Endothelium
Cancer Res.,
April 15, 2008;
68(8):
2861 - 2869.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Jiang, R. A. Borgesi, N. C. McKnight, R. Kaur, C. L. Carpenter, and S. P. Balk
Activation of Nonreceptor Tyrosine Kinase Bmx/Etk Mediated by Phosphoinositide 3-Kinase, Epidermal Growth Factor Receptor, and ErbB3 in Prostate Cancer Cells
J. Biol. Chem.,
November 9, 2007;
282(45):
32689 - 32698.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Deng, K. He, X. Wang, N. Yang, C. Thangavel, J. Jiang, S. Y. Fuchs, and S. J. Frank
Determinants of Growth Hormone Receptor Down-Regulation
Mol. Endocrinol.,
July 1, 2007;
21(7):
1537 - 1551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Kawakami, N. Inagaki, S. Salek-Ardakani, J. Kitaura, H. Tanaka, K. Nagao, Y. Kawakami, W. Xiao, H. Nagai, M. Croft, et al.
Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3
PNAS,
January 3, 2006;
103(1):
153 - 158.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Saharinen, K. Kerkela, N. Ekman, M. Marron, N. Brindle, G. M. Lee, H. Augustin, G. Y. Koh, and K. Alitalo
Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2
J. Cell Biol.,
April 25, 2005;
169(2):
239 - 243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Gomez-Guerrero, O. Lopez-Franco, G. Sanjuan, P. Hernandez-Vargas, Y. Suzuki, G. Ortiz-Munoz, J. Blanco, and J. Egido
Suppressors of Cytokine Signaling Regulate Fc Receptor Signaling and Cell Activation during Immune Renal Injury
J. Immunol.,
June 1, 2004;
172(11):
6969 - 6977.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Aittomaki, J. Yang, E. W. Scott, M. C. Simon, and O. Silvennoinen
Molecular basis of Stat1 and PU.1 cooperation in cytokine-induced Fc{gamma} receptor I promoter activation
Int. Immunol.,
February 1, 2004;
16(2):
265 - 274.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. A. Abassi, M. Rehn, N. Ekman, K. Alitalo, and K. Vuori
p130Cas Couples the Tyrosine Kinase Bmx/Etk with Regulation of the Actin Cytoskeleton and Cell Migration
J. Biol. Chem.,
September 12, 2003;
278(37):
35636 - 35643.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Saharinen, M. Vihinen, and O. Silvennoinen
Autoinhibition of Jak2 Tyrosine Kinase Is Dependent on Specific Regions in Its Pseudokinase Domain
Mol. Biol. Cell,
April 1, 2003;
14(4):
1448 - 1459.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Junttila, R. P. Bourette, L. R. Rohrschneider, and O. Silvennoinen
M-CSF induced differentiation of myeloid precursor cells involves activation of PKC-{delta} and expression of Pkare
J. Leukoc. Biol.,
February 1, 2003;
73(2):
281 - 288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Saharinen and O. Silvennoinen
The Pseudokinase Domain Is Required for Suppression of Basal Activity of Jak2 and Jak3 Tyrosine Kinases and for Cytokine-inducible Activation of Signal Transduction
J. Biol. Chem.,
November 27, 2002;
277(49):
47954 - 47963.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pesu, S. Aittomaki, K. Takaluoma, A. Lagerstedt, and O. Silvennoinen
p38 Mitogen-activated Protein Kinase Regulates Interleukin-4-induced Gene Expression by Stimulating STAT6-mediated Transcription
J. Biol. Chem.,
October 4, 2002;
277(41):
38254 - 38261.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Yang, O. Kim, J. Wu, and Y. Qiu
Interaction between Tyrosine Kinase Etk and a RUN Domain- and FYVE Domain-containing Protein RUFY1. A POSSIBLE ROLE OF ETK IN REGULATION OF VESICLE TRAFFICKING
J. Biol. Chem.,
August 9, 2002;
277(33):
30219 - 30226.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Aittomaki, J. Yang, E. W. Scott, M. C. Simon, and O. Silvennoinen
Distinct functions for signal transducer and activator of transcription 1 and PU.1 in transcriptional activation of Fc gamma receptor I promoter
Blood,
July 18, 2002;
100(3):
1078 - 1080.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Isaksen, H. Baumann, B. Zhou, S. Nivollet, A. G. Farr, S. D. Levin, and S. F. Ziegler
Uncoupling of Proliferation and Stat5 Activation in Thymic Stromal Lymphopoietin-Mediated Signal Transduction
J. Immunol.,
April 1, 2002;
168(7):
3288 - 3294.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Takesono, L. D. Finkelstein, and P. L. Schwartzberg
Beyond calcium: new signaling pathways for Tec family kinases
J. Cell Sci.,
January 8, 2002;
115(15):
3039 - 3048.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Frasor, U. Barkai, L. Zhong, A. T. Fazleabas, and G. Gibori
PRL-Induced ER{alpha} Gene Expression Is Mediated by Janus Kinase 2 (Jak2) While Signal Transducer and Activator of Transcription 5b (Stat5b) Phosphorylation Involves Jak2 and a Second Tyrosine Kinase
Mol. Endocrinol.,
November 1, 2001;
15(11):
1941 - 1952.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Kube, U. Holtick, M. Vockerodt, T. Ahmadi, B. Haier, I. Behrmann, P. C. Heinrich, V. Diehl, and H. Tesch
STAT3 is constitutively activated in Hodgkin cell lines
Blood,
August 1, 2001;
98(3):
762 - 770.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Rajantie, N. Ekman, K. Iljin, E. Arighi, Y. Gunji, J. Kaukonen, A. Palotie, M. Dewerchin, P. Carmeliet, and K. Alitalo
Bmx Tyrosine Kinase Has a Redundant Function Downstream of Angiopoietin and Vascular Endothelial Growth Factor Receptors in Arterial Endothelium
Mol. Cell. Biol.,
July 15, 2001;
21(14):
4647 - 4655.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-Y. Cho, R. Léveillé, R. Kao, B. Rousset, A. F. Parlow, W. E. Burak Jr., E. L. Mazzaferri, and S. M. Jhiang
Hormonal Regulation of Radioiodide Uptake Activity and Na+/I- Symporter Expression in Mammary Glands
J. Clin. Endocrinol. Metab.,
August 1, 2000;
85(8):
2936 - 2943.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. Aittomaki, M. Pesu, B. Groner, O. A. Janne, J. J. Palvimo, and O. Silvennoinen
Cooperation Among Stat1, Glucocorticoid Receptor, and PU.1 in Transcriptional Activation of the High-Affinity Fc{gamma} Receptor I in Monocytes
J. Immunol.,
June 1, 2000;
164(11):
5689 - 5697.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Saharinen, K. Takaluoma, and O. Silvennoinen
Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain
Mol. Cell. Biol.,
May 15, 2000;
20(10):
3387 - 3395.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
C. A. Peters, E. T. Maizels, M. C. Robertson, R. P.C. Shiu, M. S. Soloff, and M. Hunzicker-Dunn
Induction of Relaxin Messenger RNA Expression in Response to Prolactin Receptor Activation Requires Protein Kinase C {delta} Signaling
Mol. Endocrinol.,
April 1, 2000;
14(4):
576 - 590.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
Y.-T. Tsai, Y.-H. Su, S.-S. Fang, T.-N. Huang, Y. Qiu, Y.-S. Jou, H.-m. Shih, H.-J. Kung, and R.-H. Chen
Etk, a Btk Family Tyrosine Kinase, Mediates Cellular Transformation by Linking Src to STAT3 Activation
Mol. Cell. Biol.,
March 15, 2000;
20(6):
2043 - 2054.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
T. A. H. Jarvinen, M. Tanner, V. Rantanen, M. Barlund, A. Borg, S. Grenman, and J. Isola
Amplification and Deletion of Topoisomerase II{alpha} Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast Cancer
Am. J. Pathol.,
March 1, 2000;
156(3):
839 - 847.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. E. Kovanen, I. Junttila, K. Takaluoma, P. Saharinen, L. Valmu, W. Li, and O. Silvennoinen
Regulation of Jak2 tyrosine kinase by protein kinase C during macrophage differentiation of IL-3-dependent myeloid progenitor cells
Blood,
March 1, 2000;
95(5):
1626 - 1632.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pesu, K. Takaluoma, S. Aittomaki, A. Lagerstedt, K. Saksela, P. E. Kovanen, and O. Silvennoinen
Interleukin-4-induced transcriptional activation by Stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of Stat6
Blood,
January 15, 2000;
95(2):
494 - 502.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Wen, H. H. Lin, H.-M. Shih, H.-J. Kung, and D. K. Ann
Kinase Activation of the Non-receptor Tyrosine Kinase Etk/BMX Alone Is Sufficient to Transactivate STAT-mediated Gene Expression in Salivary and Lung Epithelial Cells
J. Biol. Chem.,
December 31, 1999;
274(53):
38204 - 38210.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Isaksen, H. Baumann, P. A. Trobridge, A. G. Farr, S. D. Levin, and S. F. Ziegler
Requirement for Stat5 in Thymic Stromal Lymphopoietin-Mediated Signal Transduction
J. Immunol.,
December 1, 1999;
163(11):
5971 - 5977.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Takahashi, K. Fukuda, J. Pan, H. Kodama, M. Sano, S. Makino, T. Kato, T. Manabe, and S. Ogawa
Characterization of Insulin-Like Growth Factor-1-Induced Activation of the JAK/STAT Pathway in Rat Cardiomyocytes
Circ. Res.,
November 12, 1999;
85(10):
884 - 891.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Hornia, Z. Lu, T. Sukezane, M. Zhong, T. Joseph, P. Frankel, and D. A. Foster
Antagonistic Effects of Protein Kinase C alpha and delta on Both Transformation and Phospholipase D Activity Mediated by the Epidermal Growth Factor Receptor
Mol. Cell. Biol.,
November 1, 1999;
19(11):
7672 - 7680.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Jain, T. Zhang, W. H. Kee, W. Li, and X. Cao
Protein Kinase C delta Associates with and Phosphorylates Stat3 in an Interleukin-6-dependent Manner
J. Biol. Chem.,
August 20, 1999;
274(34):
24392 - 24400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nieborowska-Skorska, M. A. Wasik, A. Slupianek, P. Salomoni, T. Kitamura, B. Calabretta, and T. Skorski
Signal Transducer and Activator of Transcription (STAT)5 Activation by BCR/ABL Is Dependent on Intact Src Homology (SH)3 and SH2 Domains of BCR/ABL and Is Required for Leukemogenesis
J. Exp. Med.,
April 19, 1999;
189(8):
1229 - 1242.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. D. Levin, R. M. Koelling, S. L. Friend, D. E. Isaksen, S. F. Ziegler, R. M. Perlmutter, and A. G. Farr
Thymic Stromal Lymphopoietin: A Cytokine That Promotes the Development of IgM+ B Cells In Vitro and Signals Via a Novel Mechanism
J. Immunol.,
January 15, 1999;
162(2):
677 - 683.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Corey and S. M. Anderson
Src-Related Protein Tyrosine Kinases in Hematopoiesis
Blood,
January 1, 1999;
93(1):
1 - 14.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-Y. Jui, R.-J. Tseng, X. Wen, H.-I Fang, L.-M. Huang, K.-Y. Chen, H.-J. Kung, D. K. Ann, and H.-M. Shih
Protein-tyrosine Phosphatase D1, a Potential Regulator and Effector for Tec Family Kinases
J. Biol. Chem.,
December 22, 2000;
275(52):
41124 - 41132.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-J. Schuringa, L. V. Dekker, E. Vellenga, and W. Kruijer
Sequential Activation of Rac-1, SEK-1/MKK-4, and Protein Kinase Cdelta Is Required for Interleukin-6-induced STAT3 Ser-727 Phosphorylation and Transactivation
J. Biol. Chem.,
July 13, 2001;
276(29):
27709 - 27715.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Mahajan, A. Vassilev, N. Sun, Z. Ozer, C. Mao, and F. M. Uckun
Transcription Factor STAT5A Is a Substrate of Bruton's Tyrosine Kinase in B Cells
J. Biol. Chem.,
August 10, 2001;
276(33):
31216 - 31228.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
Abstract
Introduction
Abstract